New MSF report investigates acute violence and lack of protection suffered by civilians in Central African Republic

MSF is supporting a patent challenge filed in India by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson from extending its monopoly on the tuberculosis drug bedaquiline.

The Ebola Treatment Centres operated by MSF and the Ministry of Health in Katwa and Butembo are participating in a randomized controlled trial of four potential Ebola-treatments in North Kivu, Democratic Republic of Congo. 

Between August 2017 and December 2018, MSF teams have provided one million medical consultations to refugees and the local community.

Support Doctors Without Borders (MSF) by making an online donation today. Your donation can shed some light.